Screener
Ginkgo Bioworks
DNAGinkgo Bioworks operates a horizontal platform for cell engineering and biosecurity, designed to make biology easier to engineer through automation, software, and data.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$21.6M
EPS estimate-$0.58
Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Ginkgo Bioworks operates a horizontal platform for cell engineering and biosecurity, designed to make biology easier to engineer through automation, software, and data. The company provides biological R&D services and tools to customers across diverse industries, enabling them to discover, optimize, and manufacture bio-based products without maintaining extensive in-house laboratory infrastructure.
Competitive position
A leading horizontal platform provider that competes by offering scale and automation efficiencies that exceed traditional 'by-hand' laboratory R&D.
GeographiesGlobal, United States
Customer segmentsEnterprise, Government, Academic Institutions
Business modelR&D services, Platform-as-a-Service, Licensing, Royalty-based
SuppliersLife science tool manufacturers, DNA synthesis providers, Cloud computing providers, Laboratory consumable distributors
CustomersDrug developers, Food and nutrition companies, Crop protection manufacturers, Public health agencies
CountryUnited States of America
Listed2021
Employees1.2K
CEOJason Kelly
SectorHealthcare
IndustryBiotechnology
Websiteginkgobioworks.com
FilingsSEC EDGAR
FAQ
- What is Ginkgo Bioworks's market cap?
- Ginkgo Bioworks (DNA) has a market capitalization of $475.4M and trades on NYSE.
- What is Ginkgo Bioworks's revenue and profitability?
- Ginkgo Bioworks generated $111.9M in trailing twelve-month revenue with a net loss of $290.8M, representing a net margin of -260.0%. Gross margin stands at 91.8%, with free cash flow of -$174.8M. The latest reported period is Q2 2026.
- Who are Ginkgo Bioworks's competitors?
- Ginkgo Bioworks's key competitors include Charles River Laboratories, Codexis, AbCellera, and others. These companies compete in similar markets and product categories.
- Who does Ginkgo Bioworks partner with?
- Ginkgo Bioworks's notable partners include Google Cloud, Bayer Crop Science, Virica Biotech, and others.
- What subsidiaries does Ginkgo Bioworks have?
- Ginkgo Bioworks's subsidiaries include Zymergen.
- Where is Ginkgo Bioworks headquartered?
- Ginkgo Bioworks is headquartered in United States of America and employs approximately 1,218 people. It has been publicly traded since 2021.
